All In Biotech

Drug Trial Radar · NCT03374800

Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial

Last checked: Nov 19, 2026Latest source record: Sep 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 4,800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,800

Actual

Start

Jul 9, 2018

Primary completion

Oct 31, 2023

Study completion Jan 31, 2024

Sponsor

Lead sponsor
McMaster UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Canadian Institutes of Health Research (CIHR); Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; National Health and Medical Research Council, Australia
First posted
Dec 15, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients who are critically ill in the in the Intensive Care Unit (ICU), especially those who need a breathing machine, can develop ulcers in the stomach that bleed. To prevent bleeding, many such patients around the world receive a drug called pantoprazole that decreases acid production. However, today, compared to decades ago, critically ill patients rarely develop upper gastrointestinal bleeding. This decrease is likely due to modern medicine, better resuscitation and earlier feeding. There may also be harms associated with pantoprazole and other drugs that reduce acid levels in the stomach including lung infections (pneumonia) and bowel infections (Clostridioides difficile). Studies in this area are old and of modest quality. Therefore, it is difficult to know whether pantoprazole does decrease stomach bleeding these days, or whether the possible harms of lung and bowel infections are actually more common and more serious problems. The goal of this international study is to determine if, in critically ill patients using breathing machines, the use of pantoprazole is effective in preventing bleeding from stomach ulcers or whether it causes more problems such as lung infection (pneumonia) and bowel infection (Clostridioides difficile), or whether pantoprazole has no effect at all. Whether the harms are worth the benefits, and whether the benefits are worth the costs, will be determined by an economic analysis to inform patients, families, clinicians, and healthcare systems globally.

Conditions

  • Gastrointestinal Hemorrhage (Clinically Important, Upper)

Interventions

  • Placebo (0.9% saline)Drug

    normal saline

  • PantoprazoleDrug

    40 mg powder for injection reconstituted with 0.9% saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of clinically important upper gastro-intestinal bleedingTime frame: 90 days (In ICU or resulting in ICU readmission, censored at 90 days after randomization)
  2. Primary Safety Outcome: 90 Day MortalityTime frame: 90 days post randomization

Locations

67 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Nebraska - Nebraska Medical Center

    Omaha, Nebraska

  • Bankstown-Lidcombe Hospital

    Bankstown, New South Wales, Australia

  • Blacktown Hospital

    Blacktown, New South Wales, Australia

  • Sutherland Hospital

    Caringbah, New South Wales, Australia

  • Gosford Hospital

    Gosford, New South Wales, Australia

  • Nepean Hospital

    Kingswood, New South Wales, Australia

  • St George Hospital

    Kogarah, New South Wales, Australia

  • Royal North Shore Hospital

    Saint Leonards, New South Wales, Australia

  • Wollongong Hospital

    Wollongong, New South Wales, Australia

  • Royal Brisbane Womens Hospital

    Brisbane, Queensland, Australia

  • Ipswich Hospital

    Ipswich, Queensland, Australia

  • Mater Hospital

    South Brisbane, Queensland, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Bendigo Health

    Bendigo, Victoria, Australia

  • Geelong University Hospital

    Geelong, Victoria, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • Alfred Hospital

    Melbourne, Victoria, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • Epworth Hospital

    Melbourne, Victoria, Australia

  • Sociedade Hospitalar Angelina Caron

    Campina Grande do Sul, Brazil

  • Beneficência Social Bom Samaritano

    Governador Valadares, Brazil

  • Foothills Hospital

    Calgary, Alberta, Canada

  • Peter Lougheed Hospital

    Calgary, Alberta, Canada

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

  • Nanaimo Regional General Hospital

    Nanaimo, British Columbia, Canada

  • Royal Columbian Hospital

    New Westminster, British Columbia, Canada

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Vancouver Island Health Authority

    Victoria, British Columbia, Canada

  • St. Boniface Hospital

    Winnipeg, Manitoba, Canada

  • Health Science Center Winnipeg

    Winnipeg, Manitoba, Canada

  • Grace Hospital

    Winnipeg, Manitoba, Canada

  • Saint John Regional Hospital

    Saint John, New Brunswick, Canada

  • QEII Health Sciences Centre

    Halifax, Nova Scotia, Canada

  • William Osler Hospital, McKenzie Health, Brampton Civic Hospital

    Brampton, Ontario, Canada

  • Brantford General Hospital

    Brantford, Ontario, Canada

  • Cambridge Memorial Hospital

    Cambridge, Ontario, Canada

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, Canada

  • Hamilton Health Science Center - General Hospital

    Hamilton, Ontario, Canada

  • Hamilton Health Science Center - Juravinski Hospital

    Hamilton, Ontario, Canada

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.